On Oct 25, major Wall Street analysts update their ratings for $DexCom (DXCM.US)$, with price targets ranging from $75 to $120.
Morgan Stanley analyst Patrick Wood maintains with a hold rating, and maintains the target price at $75.
Citi analyst Joanne Wuensch maintains with a buy rating.
Wells Fargo analyst Larry Biegelsen maintains with a buy rating, and adjusts the target price from $80 to $90.
TD Cowen analyst Josh Jennings maintains with a buy rating, and adjusts the target price from $160 to $100.
Oppenheimer analyst Steven Lichtman maintains with a buy rating, and adjusts the target price from $115 to $105.
Furthermore, according to the comprehensive report, the opinions of $DexCom (DXCM.US)$'s main analysts recently are as follows:
DexCom's third-quarter sales surpassed projections primarily due to stronger-than-anticipated international performance, despite U.S. figures falling short of expectations. This can be linked to the decline in new patient additions in the second quarter and the anticipated effects of product mix. The company's guidance for sales and margins in 2024, as well as its 2025 objectives, remain unchanged.
Here are the latest investment ratings and price targets for $DexCom (DXCM.US)$ from 11 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
